Oklahoma Senate Bill SB958

Oklahoma 2024 Regular Session

• Introduced: 2/6/23
• Refer: 2/7/23

Caption

Health care; authorizing Certified Registered Nurse Anesthetist to provide interventional pain management services and operate certain facilities under specified conditions. Effective date.

Impact

If passed, SB958 would significantly modify the existing framework surrounding pain management in Oklahoma. It would enable CRNAs to play a more collaborative role in managing chronic pain, particularly in partnership with licensed physicians. The legislation underscores efforts to address chronic pain treatment through alternative avenues, potentially increasing access to care for patients. Additionally, it introduces limitations, as CRNAs would not have the authority to prescribe opioids or controlled substances for offsite use, maintaining checks on the prescription practices.

Summary

Senate Bill 958 introduces amendments to the Oklahoma Interventional Pain Management and Treatment Act. The bill aims to expand the authority of Certified Registered Nurse Anesthetists (CRNAs) by allowing them to provide interventional pain management services under specific conditions. This includes the operation of certain facilities where such services are delivered. Moreover, the bill lays out definitions and clarifications around key terms such as 'chronic pain' and 'interventional pain management'. It specifies the procedures that CRNAs may undertake, particularly focusing on non-surgical techniques that can assist in pain management.

Contention

Although the bill addresses a critical need for updated pain management protocols, it may not be without controversy. Opponents may raise concerns about the expansion of responsibilities for CRNAs, particularly regarding their capacity to operate pain management facilities. There may be discussions about ensuring that patient care quality and safety are not compromised as a result of these changes, given the complexities associated with chronic pain therapies and management. Balancing the increased autonomy for CRNAs with adequate supervisory and collaboration requirements could be a focal point of debate.